StockData
PGENNasdaqPharmaceutical PreparationsFiscal year ends December 31

PRECIGEN, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$6.66+0.28 (+4.31%)

Close on Oct 19, 2026

Market cap
$2.76B
P/E (TTM)
–
Dividend yield
–

PRECIGEN, INC. balance sheet

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin
–
Operating margin
-1141.1%
Net margin
-1628.5%
Return on equity, FY2025
-843.6%

Financial strength

Current ratio
4.58
Debt to equity
2.15
Debt to assets
55.1%
Cash to current liabilities
55.6%

Valuation

P/E ratio
–
Price to sales
284.51
Price to book
63.23
Dividend yield
–